Michael Gerard Campbell - Nov 27, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role: EVP & CFO
Signature: /s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol: CMRA
Transactions as of: Nov 27, 2023
Transactions value $: $708
Form type: 4
Date filed: 11/28/2023, 04:25 PM
Previous filing: Sep 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRA	Common Stock	Purchase	$708	+10K	+40%	$0.07	35K	Nov 27, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0675 to $0.07125, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0675 to $0.07125, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.